Used in the evaluation of canine conjunctivitis to diagnose tear deficiency as a contributing factor to ocular surface diseases and to assess lacrimal gland function.
LEARN MOREGilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.
LEARN MOREA powerful first-line, broad-spectrum topical medication administered twice a day for 7 days to treat otitis external in dogs.
LEARN MORE